跳至主要内容
临床试验/NCT00174512
NCT00174512已完成1 期

A Methodological Open-Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarisation and QT Interval At Fixed Heart Rate Under Autonomic Blockade

Pfizer6 个研究点 分布在 2 个国家目标入组 36 人开始时间: 2005年3月最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
Pfizer
入组人数
36
试验地点
6
主要终点
QT and QTc changes at two different pacing rates in atrially paced patients

研究概览

简要总结

To assess the effects of GTN on QT and QTc in subjects with And without atrial pacing. This will be done with and without autonomic blockade at two different pacing rates. Moxifloxacin effect on QT and QTc will also be assessed in atrially paced patients at two different pacing rates with and without autonomic blockade

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Ect
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with pace-makers but otherwise normal ventricular function

排除标准

  • Nitrates, beta blockers

结局指标

主要结局

QT and QTc changes at two different pacing rates in atrially paced patients

次要结局

  • Change in QT and QTcF before and after Moxifloxacin with and without autonomic blockade at each pacing rate Change in QT and QTcF before and after autonomic blockade at each pacing rate

研究者

发起方
Pfizer
申办方类型
Industry

研究点 (6)

Loading locations...

相似试验